Compound Evidence File
#EC-2026-0252
NA Selank Amidate
Filed under Peptides. The bureau holds 129 laboratory returns for this compound from 47 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
47 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 8 Feb 2026 | 6 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 23 Dec 2025 | 13 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 10.0 | 10.0 | 12 Feb 2026 | 21 Jun 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 22 Feb 2026 | 4 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 20 Dec 2025 | 9 Jan 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Jan 2026 | 25 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Jun 2026 | 15 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 10.0 | 9.9 | 10.0 | 11 Jun 2026 | 9 Aug 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 10.0 | 10.0 | 10.0 | 15 Nov 2025 | 14 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Jan 2026 | 14 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 9.9 | 9.9 | 10.0 | 6 Mar 2026 | 11 May 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Feb 2026 | 17 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Feb 2026 | 14 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 16 Apr 2026 | 25 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 9.9 | 9.9 | 9.9 | 8 Apr 2026 | 20 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 3 | 9.9 | 9.9 | 10.0 | 26 Mar 2026 | 6 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Dec 2025 | 6 May 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 9.9 | 9.9 | 10.0 | 28 Feb 2026 | 4 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Feb 2026 | 26 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 2 | 9.9 | 9.9 | 9.9 | 13 Mar 2026 | 13 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 26 Mar 2026 | 20 Jul 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.7 | 9.7 | 9.7 | 28 Mar 2025 | 28 Mar 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 9.5 | 9.4 | 9.6 | 11 Jun 2025 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.9 | 7.7 | 9.8 | 23 May 2026 | 23 May 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 8.9 | 8.9 | 8.9 | 28 Mar 2025 | 28 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.7 | 8.1 | 9.0 | 23 May 2026 | 23 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.7 | 8.5 | 8.8 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.6 | 7.7 | 9.4 | 24 May 2026 | 24 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 8.6 | 8.6 | 8.6 | 6 May 2025 | 6 May 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 8.5 | 8.5 | 8.5 | 2 Apr 2025 | 2 Apr 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.2 | 6.9 | 9.9 | 24 May 2026 | 24 May 2026 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 8.0 | 8.0 | 8.0 | 2 Apr 2025 | 2 Apr 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 7.9 | 7.9 | 7.9 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 | 20 Jun 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.6 | 6.6 | 6.6 | 6 May 2025 | 6 May 2025 |
| Zenith Jove Peptide ZJCASE #VI-2026-0570 | X | 2 | 6.5 | 5.6 | 7.4 | 9 Jun 2025 | 25 May 2026 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 | 3 Jul 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 5.9 | 5.9 | 5.9 | 14 Jan 2025 | 14 Jan 2025 |
| NUPEPS PeptidesCASE #VI-2026-0896 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Feb 2025 | 13 Feb 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 5.1 | 5.1 | 5.1 | 14 Jan 2025 | 14 Jan 2025 |
| Evolve BioPepCASE #VI-2026-0755 | X | 1 | 4.1 | 4.1 | 4.1 | 3 Jun 2025 | 3 Jun 2025 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 3.7 | 3.7 | 3.7 | 17 Dec 2024 | 17 Dec 2024 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 2.0 | 2.0 | 2.0 | 20 Jun 2025 | 20 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
Open any subject to view the batch-level evidence for NA Selank Amidate alone.